CAS 128478-69-3

1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-,hydrogen sulfate (ester), (6S)-

Description:

1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, hydrogen sulfate (ester), (6S)-, is a complex organic compound characterized by its naphthalene structure, which is a fused bicyclic aromatic hydrocarbon. The presence of the tetrahydro group indicates that the compound has undergone partial hydrogenation, resulting in a saturated ring system. The propyl and thienyl substituents suggest that the compound has significant steric and electronic properties, potentially influencing its reactivity and solubility. The hydrogen sulfate ester functional group indicates that it may exhibit acidic properties and could participate in various chemical reactions, including esterification and hydrolysis. This compound may also have biological activity due to its amine and aromatic components, which are often associated with pharmacological effects. Overall, its unique structure and functional groups suggest potential applications in medicinal chemistry or as a synthetic intermediate in organic synthesis. However, specific safety and handling information should be consulted due to the potential hazards associated with chemical compounds.

Formula: C₁₉H₂₅NO₄S₂

Rotigotine Sulfate

CAS: 128478-69-3

Formula: C₁₉H₂₅NO₄S₂

Color and Shape: White To Off-White Solid

Molecular weight: 395.53

Ref: 4Z-R-4312

Rotigotine sulfate

CAS: 128478-69-3

Rotigotine is a drug that belongs to the group of pharmaceutical formulations. It is an unlabeled drug that has been shown to be effective in the treatment of depression. Rotigotine may be administered through a transdermal patch or by iontophoresis, which is a technique used to administer drugs through the skin. The mechanism of action is not known, but it may involve the inhibition of monoamine reuptake and/or alteration of intracellular levels of catecholamines. Rotigotine sulfate has a high affinity for dopamine receptors and increases plasma concentrations of dopamine by inhibiting its reuptake into presynaptic neurons. This leads to increased concentrations of dopamine in synaptic clefts and an increase in postsynaptic receptor binding.

Formula: C₁₉H₂₅NO₄S₂

Purity: Min. 95%

Molecular weight: 395.5 g/mol

Ref: 3D-DFA47869